Plasma Fibrinogen Qualification as a Drug Development Tool in Chronic Obstructive Pulmonary Disease. Perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification Consortium (Q38690517)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Plasma Fibrinogen Qualification as a Drug Development Tool in Chronic Obstructive Pulmonary Disease. Perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification Consortium
scientific article

    Statements

    Plasma Fibrinogen Qualification as a Drug Development Tool in Chronic Obstructive Pulmonary Disease. Perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification Consortium (English)
    Bruce E Miller
    Stephen I Rennard
    Armin Furtwaengler
    Nancy Leidy
    Michael Lowings
    Ubaldo J Martin
    Thomas R Martin
    Debora D Merrill
    Jeffrey Snyder
    John Walsh
    8 January 2016
    607-613

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit